Market Tracker

05/25 6:52am ET

Genomic Health Inc (NASDAQ:GHDX)

26.68
Delayed Data
As of May 24
 +1.20 / +4.71%
Today’s Change
20.05
Today|||52-Week Range
35.79
-24.20%
Year-to-Date
Genomic Health (GHDX): Q1 Results Strong, Costs Escalate
May 24 / Zacks.com - Paid Partner Content
Today's Weak On High Volume Stock: Genomic Health (GHDX)
May 18 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close25.48
Today’s open25.59
Day’s range25.59 - 27.39
Volume340,416
Average volume (3 months)213,744
Market cap$841.2M
Dividend yield--
Data as of 05/24/2016

Growth & Valuation

Earnings growth (last year)-32.05%
Earnings growth (this year)+56.15%
Earnings growth (next 5 years)+79.05%
Revenue growth (last year)+4.26%
P/E ratioNM
Price/Sales3.97
Price/Book5.99

Competitors

 Today’s
change
Today’s
% change
VIVOMeridian Bioscience ...+0.50+2.67%
AMAGAMAG Pharmaceuticals...+0.83+4.41%
NTRANatera Inc+0.28+2.31%
ALRPRBAlere Inc+1.50+0.47%
Data as of 05/24/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$287.5M
Annual profit (last year)-$33.3M
Net profit margin-11.59%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Kimberly J. Popovits
Chief Operating &
Financial Officer
G. Bradley Cole
Corporate headquarters
Redwood City, California

Forecasts